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I have chosen some thoughts about recent
clinical advances in the diagnosis of cerebral vascular disease, which I feel are appropriate for this
paper, confining my discussion to the signs, symptoms, natural history, and risk factors of cerebral
vascular disease.
Atherosclerosis and stenosis of the cerebral
vessels result in occlusion and embolization of the
brain parenchymatous vessels, particularly if the ·
atherosclerotic lesions of the vessels not only stenose
but cause ulcerated lesions as well, which will give
rise to fibrinoplatelet emboli and even large, red
emboli. This process results in slow blood flow,
turbulence, erythrocyte and platelet aggregationwith local anoxia resulting in endothelial damage,
the loss of plasma fluid-resulting in brain edema,
and compression of capillaries and venules. This
vicious cycle is depicted in Figure 1, showing a
worsening of the ischemic and hemorrhagic infarction. In the area of circulation around the ischemia,
hyperproteinemia and hemoconcentration occur,
which tend to cause deposition of the platelets.
One can easily see these platelets under direct
examination of the microcirculation of the brain,
showing increased viscosity and the tendency toward
thrombosis and further infarction.
Hypertension will promote atherosclerosis, and
certain other systemic factors such as hypotension
or lowered blood pressure, particularly much below
80-90 mm H g (systolic), will worsen the situation
because of distorted autoregulation. Associated poly,:, This is an edited transcription of a lecture presented
by Dr. Meyer at the 27th Annual Stoneburner Lecture
Series, February 7, 1974, at the Medical College of Virginia, Richmond.
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cythemia or sickle cell disease will be aggravated
by the situation.
Conversely, anticoagulants and platelet inhibitors tend to prevent the aggregation of these
platelets and erythrocytes as welt as preventing the
development of thrombosis. Systemic dehydration
will have an adverse effect while collateral blood
flow enhancement will tend to improve the situation. Hyperlipidemia and hyperlipemia will cause
aggravation for several reasons-they promote
atherosclerosis and they enhance the tendency toward platelet aggregation and changes in the properties of the blood. Hypothermia will tend to protect
the patient by decreasing brain metabolism; systemic anoxia will make him worse. Neurotransmitters are released, probably as a result of the
deleterious changes.
Let me summarize the risk factors with which
the American Heart Association Committee concerned itself in 1971 ( 1), which we now agree are
reasonably well established (Table 1). A hypertension of 160/ 95 mm Hg is present in at least
85 % of cases-a significant risk factor, the control
of which is one of the great advances in prevention
of stroke. EKG abnormalities occur in 60- 70% of
our patients with stroke, consisting of left ventricular hypertrophy (LVH) , myocardial infarction
(Ml), or a recent or old dysrhythmia. Clinical
angina, myocardial infarction, claudication, diminished pulses, bruits-all are associated with a stroke
patient and should be sought. Diabetes mellitus
occurs, depending upon how you evaluate it, in at
least 30-40% of these patients. Certainly, an elevated fasting blood sugar and an abnormal glucose
tolerance test or a two-hour postprandial blood
sugar exceeding 160 mg % should be considered sigMCV QUARTERLY 10(3): 134-138, 1974

135

MEYER: DIAGNOSIS OF CEREBRAL VASCULAR DISEASE

nificant. Recently, we have been studying the blood
lipid profile, another important factor, with Dr.
Gotto at our institution. Type IV lipidemia, particularly, is a risk factor that occurs in approximately 30% of these patients. Other factorssmoking, polycythemia, erythrocytosis, gout, and
hyperuricemia should be evaluated. Of our patients
with cerebral vascular symptoms and extracranial
occlusive disease, 43% had hyperlipoproteinemia,
and almost all of these were type IV. Of our patients with intracranial small and large vessel lesions,
20% had hyperlipoproteinemia, but of those with
intracranial small vessel disease, only 3% had hyperlipoproteinemia. As might be expected, of those with
combined extra- and intracranial lesions, there is
an incidence of 25%. Those with a normal
angiogram have, essentially, a normal lipoprotein
pattern. In summary, one can say that hyperlipoproteinemia type IV is a significant aspect of extracranial occlusive disease.
It is wise in evaluating your patients, particularly the young patients with hypotension and
extracranial occlusive cerebral vascular disease, to
look for fibromuscular dysplasia. Acute myocardial
infarction is seen in 10% of patients with acute
stroke and in 60% of those with chronic arteriosclerotic heart disease. As illustrated in Table 2, a
stroke-prone individual is one who has not yet had
a stroke but is likely to because of the risk factors
present in his profile. Thus, a patient with hypotension, diabetes, hyperlipidemia, and/ or arteriosclerotic heart disease, who is obese or a heavy
smoker, is extremely apt, on a prospective clinical
trial period, to have a stroke and is at great risk.
Similarly, patients having transient ischemic
attacks (TIA's) or reversible ischemic neurological
deficits (RIND's) will proceed to a stroke 30-50%
of the time within a five-year period. Transient
ischemic attack is a neurological deficit existing,
due to cerebral vascular disease, for 24 hours or
less; whereas reversible ischemic neurological deficit
is a little stroke lasting longer than 24 hours but
with recovery in about three weeks. A patient who
has had a neurological deficit for longer than 24
hours, progressing in the acute stage is said to have
a stroke in evolution. A stabilized neurological
deficit appears in a patient who has a stroke in
the past and comes in sometime later in a stable
condition. Table 3 represents a summary of several
natural history studies of cerebral vascular disease,
which indicates that of those undergoing TIA's,
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one-third progress within five years to irreversible
cerebral infarction; one-third continue to have TIA's
and therefore continue to be at risk of cerebral infarction; and one-third seem to cease having TIA's
spontaneously within five years, without further neurological disorder, but they are at great risk of
suffering other complications of atherosclerosis such
as myocardial infarction.
The mechanism of TIA's is still under consideration by many scientists and physicians. Cer-

TABLE 1
RiSK FACTORS IN STROKE*

1. Hypertension of 160/ 95 mm Hg (present in 85% of
cases)
2. Cardiac Enlargement by X-ray
3. EKG Abnormalities, LVH, MI, and Dysrhythmia
4. Clinical Angina, MI, Claudication, Diminished Pulses,
and Bruits
5. Diabetes Mellitus (2 hr pp 160 mg% or more; FBS 120
mg% or more)
6. Elevated Blood Lipids (cholesterol, ~-lipoproteins,
triglycerides)
7. Smoking
8. Erythrocytosis
9. Gout-Hyperuricemia

* Reprinted by permission
sociation, Inc. (1)

of the American Heart As-
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TABLE 2

TABLE 4

CLINICAL CLASSIFICATIONS

REMEDIAL MECHANISMS iN TRANSIENT [SCHEMIC ATTACKS

I. "Stroke-prone" individual
2. TIA's and RIND's
3. Stroke in evolution and patients with moderate-tosevere neurological deficits still in acute stage
4. Stabilized neurological deficits

I.
2.
3.
4.
5.

6.

tainly, the two major headings are recurrent
fibrinoplatelet emboli and hemodynamic factors.
What are the remediable mechanisms in TIA's
(Table 4)? First of all , there is embolization for
which doctors have advanced treatment. Cardiac
dysrhythmias can cause cerebral vascular symptoms
simply by decreasing cardiac output when the rate
of the heart exceeds 160 or falls below 60. Transient
hypotension can cause cerebral vascular symptoms
as well, particularly if the patient has dysautoregulation or impaired autoregulation of the brain. Hypertension with spasm of cerebral vessels, first described many years ago and then abandoned, is now
well established as a significant factor. Hypoglycemia, a relatively rare factor, can cause localized
neurological deficits but will respond to the administration of glucose. Likewise, polycythemia, the
subclavian innominate steal syndrome, severe anemia, kinking of vessels in the neck, and external
compression may, by such things as osteophytes
and cervical spondylosis, give rise to TIA's.
While it was considered dangerous at one point
to lower elevated blood pressure in patients with
stroke or cerebral vascular symptoms, it now seems
clear that controlling the hypertension improves the
prognosis. In a series of hypertensive stroke patients
treated with Aldomet® for one-to-two weeks, we
noted that cerebral blood flow actually increased as
the mean arterial blood pressure was decreased significantly and thereby decreased cerebral vascular
resistance.
Figure 2 is a sketch of a very important concept

7.
8.
9.
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Embolization
Cardiac dysrhythmia
Transient hypotension
Severe hypertension with spasm of cerebral vessels
Hypoglycemia
Polycythemia
Subclavian, innominate steal
Severe anemia
Kinking of vessels
External compression

of how an ulcerated plaque in the carotid artery
can be a source of cerebral embolism. Recurrent
cerebral embolism with recurrent TIA's may occur
in the same distribution repeatedly-a very important warning sign. Thus the ulcerated plaque
may release the embolus which may then lodge
in the middle cerebral artery territory, causing turbulent flow. Circulating fibrinolysin, apparently
present in the body normally but probably decreased
in these patients, tends to dissolve the fibrinoplatelet deposition. Platelet aggregate inhibitors, such as
aspirin, Persantine®, sulfinpyrazone, along with anticoagulants, tend to inhibit emboli. Today, there is
a greater tendency to use platelet inhibitors rather
than anticoagulants.
We studied cerebral embolization in 42 cases
prospectively. In our patients, prosthetic heart valves
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1 / 3 --> Irreversible ce rebral infarctions
l / 3 --> Continue to have TIA's
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1 / 3 --> Cease in five years
* It is impossible to predict into which category an
individual patient with TIA's will fall .
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were important as a source of fibrinoplatelet emboli
to the brain. Rheumatic heart disease may also
cause em boli formation; arteriosclerotic heart disease
may cause emboli as a result of myocardial infarction, pacemaker failure, or dysrhythmias. Carotid
plaques emerge along with cardiac disorders as the
most common causes, accounting for almost all
emboli. There are rare causes such as aortic aneurysms with mural thrombi, carotid stenosis without
ulcerated plaque, carotid kinking, and vertebral
thrombosis. Two types of embolism can result from
the justifiable insertion of prosthetic valves, although
it must be emphasized that 90% or more of patients
receiving them show no complications from their
use, and they should be considered a great advance
in surgical treatment. The fibrinoplatelet emboli that
arise from the valve, particularly if it is a ball valve
with a rough surface, can be seen and can be treated
with Persantine®. The larger types of emboli respond
to anticoagulants.
Although we never used to think that seizures
occurred with cerebral vascular disease, it is now
quite apparent that they commonly occur in cerebral embolization. Neurological findings show that
abnormal tendon jerks. and mot.or deficits are common and cranial nerve involvement is a frequent
physical finding; herrlianopsia is relatively frequent
as well. Regarding the work-up, the arteriogram is
by far the most valuable test and will usually show
the occluded vessel early in the course of disease.
We were able to show the occluded vessel in 93%
of our cases. In 90% of cerebral embolisms, the
EEG is abnormal. The brain scan is abnormal in
91 % of the cases and the cerebrospinal fluid ( CSF)
pressure is increased in about 50% of the cases
(Table 5). The left hemisphere is involved more
often than the right in cerebral embolisms; the
incidence was about twice as high in our study.
Sixty-five percent of emboli of cardiac origin and
64% of carotid plaque origin lodge in the left hemisphere. This tendency can probably be explained
by the anatomical distribution of the aorta and the
great vessels in the neck. The innominate artery
tends to go against the vector of force or the thrust
of the cardiac output; it is somewhat protected and
emboli would tend to go to the right arm rather
than into the carotid or vertebral artery. The left
common carotid artery, however, is particularly
prone to receive the emboli, since it lies directly
in the direction of the thrust of the cardiac output.
Also, I believe the incidence of plaques is greater
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TABLE 5
Test Performed
Arteriogram
Electroencephalogram
Brain scan
CSF pressure exceeding 180 mm H,O

No. Cases
Studied % Normal % Abnormal

28

90

11

7
10
9

20

50

50

30

93

91

on the left. It could perhaps be argued also that
a patient who is dysphasic and has a left hemisphere
lesion is more likely to be diagnosed, but we rejected
that argument in our own prospective study since
we think we examined all patients very carefully.
In our institution, patients with vertebral basilar
insufficiency have a different type of transient
ischemic attack from patients with carotid emboli;
they tend to have more postural vertigo, dizziness,
photopsia, or homonymous or altitudinal hemianopsia. We feel that is because the process of ischemia
of the brain stem itself involves those centers that
are concerned with autoregulation. There is evidence
now from many laboratories showing that autoregulation, the property of the brain enabling it
to maintain a constant blood flow despite changes
in the perfusion pressure, is due, in part, to the
neurogenic innervation; this property has a brain
stem or diencephalic-brain stem origin. Ischemia in
this area wilI damage the autoregulation process.
A fall in cerebral perfusion pressure will cause a
decrease in cerebral blood flow (CBF), and the
patient will become dizzy and symptomatic. Data
from analysis of the sites of lesions in acute and
in chronic strokes correlated with the delta CBF
over the delta cerebral perfusion pressure (which
happens to be called the autoregulation index)
indicate that the effects are more severe in the
acute stages, especially in those patients with brain
stem and subcortical infarction as compared to patients with cortical infarction. Increased intracranial
pressure is relevant in cerebral infarction.
Cerebral edema can be lethal. We have tried
to combat this with hyperosmolar agents; glycerol
seems to be the best agent that we have evaluated
in cerebral vascular disease. We find that it is better
to treat the patient with 10 % glycerol intravenously
for six days rather than four. Glycerol ( one should
not use more than 10% ) seems to benefit metabolism as well as lower intracranial pressure; it is
another source of energy for the brain.
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Finally, I would like to make a few remarks
about transient global amnesia and dementia as a
result of vertebral b asilar insufficiency. Transient
global amnesia and dementia effect persons of middle
age; they have attacks of loss of memory for a period
of 24 hours and then make a more or less complete
recovery. During the attacks, they do not lose personal identity and knowledge of self, but they have
loss of memory for just about everything of recent
occurrence. They are able to carry out routine
behavior; they can respond when spoken to; they
may be rather pale and sweaty. The origin of this
interesting syndrome being unknown, epilepsy, migraine and various equivalents, and also cerebral
vascular disease were considered as possibilities.
We have studied a fairly large series of these patients,
having followed them now for an interval of twoto-three years. They actually have vertebral basilar
insufficiency symptoms in addition to the attacks
of transient global amnesia. They have drop attacks, ataxia, vertigo and nausea, vomiting, nystagmus, dizziness, light-headedness, syncope, diplopia,
oscillopsia, paresthesias alternating from side to side,
circumoral paresthesias, tremor, cortical blindness, episodic bilateral blurred vision, occipital
headaches-all of which are symptoms of vertebral
basil ar insufficiency. When we analyzed them in
terms of their age, the youngest was 48 years of age
and the oldest was 95 with a mean of about 70;
so it is a disease of late-middle-to-'early-elderly aged
individuals. We noted that the cerebral blood flow
measµred in these patients was reduced; the major
reduction was in the occipital area, in the distribu-

tion of the posterior cerebral arteries . We then
analyzed the patients for the risk factors for cerebral
vascular disease mentioned previously; it is apparent that these patients do have a high incidence
of hypertension, hyperlipidemia, coronary artery
disease of one sort or another, and diabetes mellitus.
A study of their natural histories, prospectively,
indicates th at they frequently have had recurrent
attacks of transient global amnesia, often resulting
in dementia ; this leads to amnesic stroke with permanent loss of memory and gross dementia in a
vast number of cases. These patients usually have
abnormal EEG's. Bjtemporal EEG's showing occipital slow waves are found most often; occasionally, bifrontal slow waves are seen as well. Angiograms of 12 patients revealed vertebral basilar
arterial disease in the majority of them. Occlusion
or stenosis of the posterior cerebral artery was
extremely common. Thus, clearly, this disease is
due to vertebral basilar insufficiency, and it is probable that the posterior cerebral artery is responsible
for loss of memory.
I have tried to summarize what I consider to
be recent and, I think, relevant and important clinical findings contributed by neurologists, neurosurgeons, and internists in the past few years on th e
subject of cerebral vascular disease.
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